Ligand validation:4O6D

OXN: OXTOXYNOL-10

OXN is a Ligand Of Interest in 4O6D designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4O6D_OXN_B_410	19%	29%	0.172	0.883	1.9	0.99	4	1	0	0	33%	0.3333
4O6D_OXN_A_406	18%	26%	0.168	0.872	1.9	1.14	4	2	0	0	33%	0.3333
4O6D_OXN_A_407	16%	24%	0.185	0.873	1.69	1.42	4	3	0	0	33%	0.3333
4O6D_OXN_A_408	15%	72%	0.137	0.771	0.77	0.31	-	-	0	0	56%	0.5556
4TPL_OXN_A_407	7%	26%	0.257	0.831	1.84	1.16	4	3	0	0	33%	0.3333
1UEH_OXN_B_802	72%	32%	0.076	0.96	1.75	0.98	6	4	0	0	67%	0.6667
6Z1X_OXN_A_201	39%	77%	0.132	0.913	0.36	0.55	-	-	2	0	58%	0.5778
6Z1W_OXN_A_201	22%	81%	0.194	0.891	0.3	0.52	-	-	0	0	56%	0.5556
1IKT_OXN_A_123	19%	33%	0.155	0.831	1.54	1.13	5	4	1	0	56%	0.5333
7VUD_OXN_A_601	11%	84%	0.276	0.88	0.24	0.52	-	-	0	0	53%	0.5333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.